Meeting
2013 ASCO Annual Meeting
Correlation of epidermal growth factor receptor (EGFR) mutation profile with computed tomography (CT) imaging features in lung adenocarcinomas.
Authors
Benjamin F. Chu
Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
Benjamin F. Chu , Efe Ozkan , Selnur B Erdal , Weiqiang Zhao , Konstantin Shilo , Gregory Alan Otterson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 7542)
DOI
10.1200/jco.2013.31.15_suppl.7542
Abstract #
7542
Poster Bd #
20D
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
SRC-homology 2 domain-containing phosphatase 2 (SHP2) in epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma (LUAD).
First Author: Rafael Rosell
Poster
2013 ASCO Annual Meeting
Does EGFR mutation define the histological predominant subtype of lung adenocarcinoma?
First Author: Eri Sugiyama
Poster
2011 ASCO Annual Meeting
Impact of dietary habits on epidermal growth factor receptor (EGFR) mutation status of Japanese patients with lung adenocarcinomas.
First Author: Y. Yamane
Poster
2024 ASCO Annual Meeting
Safety and efficacy of osimertinib in patients with NSCLC and uncommon tumoral EGFR mutations: A systematic review and meta-analysis.
First Author: Jonathan N. Priantti